Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    A multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma (RESPECT-MESO): Study protocol for a randomised controlled trial

    241819_241819.pdf (492.0Kb)
    Access Status
    Open access
    Authors
    Gunatilake, S.
    Brims, Fraser
    Fogg, C.
    Lawrie, I.
    Maskell, N.
    Forbes, K.
    Rahman, N.
    Morris, S.
    Ogollah, R.
    Gerry, S.
    Peake, M.
    Darlison, L.
    Chauhan, A.
    Date
    2014
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Gunatilake, S. and Brims, F. and Fogg, C. and Lawrie, I. and Maskell, N. and Forbes, K. and Rahman, N. et al. 2014. A multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma (RESPECT-MESO): Study protocol for a randomised controlled trial. Trials. 15 (367): pp. 1-8.
    Source Title
    Trials
    DOI
    10.1186/1745-6215-15-367
    School
    Curtin Medical School
    Remarks

    This open access article is distributed under the Creative Commons license https://creativecommons.org/licenses/by/4.0/

    URI
    http://hdl.handle.net/20.500.11937/15278
    Collection
    • Curtin Research Publications
    Abstract

    Background: Malignant pleural mesothelioma is an incurable cancer caused by exposure to asbestos. The United Kingdom has the highest death rate from mesothelioma in the world and this figure is increasing. Median survival is 8 to 12 months, and most patients have symptoms at diagnosis. The fittest patients may be offered chemotherapy with palliative intent. For patients not fit for systemic anticancer treatment, best supportive care remains the mainstay of management. A study from the United States examining advanced lung cancer showed that early specialist palliative care input improved patient health related quality of life and depression symptoms 12 weeks after diagnosis. While mesothelioma and advanced lung cancer share many symptoms and have a poor prognosis, oncology and palliative care services in the United Kingdom, and many other countries, vary considerably compared to the United States. The aim of this trial is to assess whether regular early symptom control treatment provided by palliative care specialists can improve health related quality of life in patients newly diagnosed with mesothelioma. Methods: This multicentre study is an non-blinded, randomised controlled, parallel group trial. A total of 174 patients with a new diagnosis of malignant pleural mesothelioma will be minimised with a random element in a 1:1 ratio to receive either 4weekly regular early specialist symptom control care, or standard care. The primary outcome is health related quality of life for patients at 12 weeks. Secondary outcomes include health related quality of life for patients at 24 weeks, carer health related quality of life at 12 and 24 weeks, patient and carer mood at 12 and 24 weeks, overall survival and analysis of healthcare utilisation and cost. Discussion: Current practice in the United Kingdom is to involve specialist palliative care towards the final weeks or months of a life-limiting illness. This study aims to investigate whether early, regular specialist care input can result in significant health related quality of life gains for patients with mesothelioma and if this change in treatment model is cost-effective. The results will be widely applicable to many institutions and patients both in the United Kingdom and internationally. Trial registration: Current controlled trials ISRCTN18955704.Date ISRCTN assigned: 31 January 2014.

    Related items

    Showing items related by title, author, creator and subject.

    • Early specialist palliative care on quality of life for malignant pleural mesothelioma: A randomised controlled trial
      Brims, Fraser; Gunatilake, S.; Lawrie, I.; Marshall, L.; Fogg, C.; Qi, C.; Creech, L.; Holtom, N.; Killick, S.; Yung, B.; Cooper, D.; Stadon, L.; Cook, P.; Fuller, E.; Walther, J.; Plunkett, C.; Bates, A.; Mackinlay, C.; Tandon, A.; Maskell, N.; Forbes, K.; Rahman, N.; Gerry, S.; Chauhan, A. (2019)
      Purpose: Malignant pleural mesothelioma (MPM) has a high symptom burden and poor survival. Evidence from other cancer types suggests some benefit in health-related quality of life (HRQoL) with early specialist palliative ...
    • A randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma - 'RESPECT-Meso'
      Brims, Fraser ; Gunatilake, S.; Lawrie, I.; Marshall, L.; Fogg, C.; Qi, C.; Maskell, N.; Forbes, K.; Rahman, N.; Morris, S.; Gerry, S.; Chauhan, A. (2018)
      Background: Malignant pleural mesothelioma (MPM) is a cancer with a high symptom burden and a median survival of less than one year. Evidence from other cancer types suggests there may be some benefit in health related ...
    • Burden of disease and benefits of exercise in fixed airway obstruction asthma
      Turner, Sian Elizabeth (2009)
      Background and research questions. The characterization of chronic persistent asthma in an older adult population is not well defined. This is due to the difficulties in separating the diagnosis of asthma from that of ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.